{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "NOK", "regularMarketChangePercent": -32.22622, "regularMarketPrice": 14.26638, "trailingAnnualDividendRate": 0.75, "trailingPE": 0.2547568, "trailingAnnualDividendYield": 0.035629455, "epsTrailingTwelveMonths": 0.56, "bookValue": 6.095, "priceToBook": 2.3406696, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "marketState": "POSTPOST", "exchange": "LSE", "shortName": "VISTIN PHARMA ASA VISTIN PHARMA", "longName": "Vistin Pharma ASA", "messageBoardId": "finmb_288390382", "exchangeTimezoneName": "Europe/London", "exchangeTimezoneShortName": "BST", "gmtOffSetMilliseconds": 3600000, "market": "gb_market", "esgPopulated": false, "regularMarketChange": -6.783619, "regularMarketTime": 1683613064, "regularMarketDayHigh": 0.0, "regularMarketDayRange": "0.0 - 0.0", "regularMarketDayLow": 0.0, "regularMarketVolume": 0, "regularMarketPreviousClose": 21.05, "bid": 0.0, "ask": 0.0, "fullExchangeName": "LSE", "financialCurrency": "NOK", "regularMarketOpen": 0.0, "fiftyTwoWeekLowChange": 14.26638, "fiftyTwoWeekRange": "0.0 - 0.0", "fiftyTwoWeekHighChange": 14.26638, "fiftyTwoWeekLow": 0.0, "fiftyTwoWeekHigh": 0.0, "symbol": "0RAM.L"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "OestensjOeveien 27", "city": "Oslo", "zip": "0661", "country": "Norway", "phone": "47 35 98 42 00", "website": "https://www.vistin.com", "industry": "", "sector": "", "longBusinessSummary": "Vistin Pharma ASA, through its subsidiary, Vistin Pharma AS, produces and sells active pharmaceutical ingredients (APIs) worldwide. It offers metformin HCl APIs and direct compressive granulates for the pharmaceutical industry. The company was founded in 1969 and is headquartered in Oslo, Norway.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Magnus  Tolleshaug", "title": "Interim CEO, Chief Commercial Officer & Commercial Director", "fiscalYear": 2021, "totalPay": {"raw": 1903000, "fmt": "1.9M", "longFmt": "1,903,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Alexander  Karlsen", "title": "Chief Financial Officer", "fiscalYear": 2021, "totalPay": {"raw": 2321000, "fmt": "2.32M", "longFmt": "2,321,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Vegard  Heggem", "title": "VP of Operations", "fiscalYear": 2021, "totalPay": {"raw": 2273000, "fmt": "2.27M", "longFmt": "2,273,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Kjell-Erik  Nordby M.B.A., M.Sc.", "age": 65, "title": "Chief Exec. Officer (Leave of Absence)", "yearBorn": 1957, "fiscalYear": 2021, "totalPay": {"raw": 4189000, "fmt": "4.19M", "longFmt": "4,189,000"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Eivind  Egeli", "title": "Director of Technical Service & Sales", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "compensationAsOfEpochDate": 1640908800, "maxAge": 86400}}], "error": null}}